TARS Stock Summary and Trading Ideas (Tarsus Pharmaceuticals | NASDAQ:TARS)

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

What symbol and exchange does Tarsus Pharmaceuticals shares trade?

Tarsus Pharmaceuticals trades on the NASDAQ stock market under the symbol TARS.

What is Tarsus Pharmaceuticals stock price doing today?

As of August 14, 2026, TARS stock price climbed to $69.20 with 422,738 million shares trading.

What is Tarsus Pharmaceuticals's Beta?

TARS has a beta of 0.52, meaning it tends to be less sensitive to market movements. TARS has a correlation of 0.02 to the broad based SPY ETF.

How much is Tarsus Pharmaceuticals worth?

TARS has a market cap of $3.02 billion. This is considered a Mid Cap stock.

How much money does Tarsus Pharmaceuticals make?

Last quarter Tarsus Pharmaceuticals reported $174 million in Revenue and -$.43 earnings per share. This beat revenue expectation by $7 million and missed earnings estimates by -$.18.

What is the highest and lowest price Tarsus Pharmaceuticals traded in the last 3 year period?

In the last 3 years, TARS traded as high as $85.25 and as low as $12.57.

What are the top ETFs holding Tarsus Pharmaceuticals?

The top ETF exchange traded funds that TARS belongs to (by Net Assets): VTI, IWM, VXF, IWO, IBB.

Is Tarsus Pharmaceuticals (TARS) a good investment?

TARS has outperformed the market in the last year with a price return of +27.8% while the SPY ETF gained +21.5%. TARS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +6.2% and +17.2%, respectively, while the SPY returned +4.0% and +3.9%, respectively.

What are the support and resistance levels for Tarsus Pharmaceuticals (TARS)?

TARS support price is $66.50 and resistance is $71.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TARS shares will trade within this expected range on the day.